SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-374624

SYN-060

[SYN] Zulu Eridanus · 57y · Female · Chinese · BMI 29.4 · ECOG 1
SVMC - Sunway Velocity · Medical Oncology · Dr. Kavitha Sundaram
IVB (T4, N3, M1c)Stable
EGFR Exon 19 Del
Clinical storyline

[SYN] Zulu Eridanus, a 57-year-old Chinese female (current, 42 pack-years, ECOG 1), presented in 2023-06 with hemoptysis (blood-streaked sputum). Workup confirmed Adenocarcinoma (Stage IV, EGFR Exon 19 Del). The MDT recommended first-line osimertinib. Current status: Stable.

HPE Results
Adenocarcinoma: Acinar and papillary
Clinical Stage
IVB (T4, N3, M1c)
Pathological Stage
IVB (T4, N3, M1c)
Adenocarcinoma Subtype
Acinar and papillary
CEA (ng/mL)
117.9
Tumor (CT/PET)
6.5 cm
PET SUV
13.85
NGS Results
EGFR Exon 19 Deletion